These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 23117931

  • 1. The androgen metabolite, 5α-androstane-3β,17β-diol, decreases cytokine-induced cyclooxygenase-2, vascular cell adhesion molecule-1 expression, and P-glycoprotein expression in male human brain microvascular endothelial cells.
    Zuloaga KL, Swift SN, Gonzales RJ, Wu TJ, Handa RJ.
    Endocrinology; 2012 Dec; 153(12):5949-60. PubMed ID: 23117931
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptor beta dependent attenuation of cytokine-induced cyclooxygenase-2 by androgens in human brain vascular smooth muscle cells and rat mesenteric arteries.
    Zuloaga KL, O'Connor DT, Handa RJ, Gonzales RJ.
    Steroids; 2012 Jul; 77(8-9):835-44. PubMed ID: 22542504
    [Abstract] [Full Text] [Related]

  • 3. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
    Oliveira AG, Coelho PH, Guedes FD, Mahecha GA, Hess RA, Oliveira CA.
    Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852
    [Abstract] [Full Text] [Related]

  • 4. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus.
    Lund TD, Hinds LR, Handa RJ.
    J Neurosci; 2006 Feb 01; 26(5):1448-56. PubMed ID: 16452668
    [Abstract] [Full Text] [Related]

  • 5. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
    Chen J, Wang WQ, Lin SX.
    J Steroid Biochem Mol Biol; 2013 Sep 01; 137():316-21. PubMed ID: 23416106
    [Abstract] [Full Text] [Related]

  • 6. The androgen metabolite, 5α-androstane-3β,17β-diol (3β-diol), activates the oxytocin promoter through an estrogen receptor-β pathway.
    Hiroi R, Lacagnina AF, Hinds LR, Carbone DG, Uht RM, Handa RJ.
    Endocrinology; 2013 May 01; 154(5):1802-12. PubMed ID: 23515287
    [Abstract] [Full Text] [Related]

  • 7. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits tumor necrosis factor alpha and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta.
    Norata GD, Cattaneo P, Poletti A, Catapano AL.
    Atherosclerosis; 2010 Sep 01; 212(1):100-6. PubMed ID: 20557886
    [Abstract] [Full Text] [Related]

  • 8. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
    Hanamura T, Niwa T, Nishikawa S, Konno H, Gohno T, Tazawa C, Kobayashi Y, Kurosumi M, Takei H, Yamaguchi Y, Ito K, Hayashi S.
    Breast Cancer Res Treat; 2013 Jun 01; 139(3):731-40. PubMed ID: 23780684
    [Abstract] [Full Text] [Related]

  • 9. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K, Richard C, Brochu G, Hould FS, Lebel S, Marceau S, Biron S, Luu-The V, Tchernof A.
    J Endocrinol; 2006 Dec 01; 191(3):637-49. PubMed ID: 17170221
    [Abstract] [Full Text] [Related]

  • 10. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells.
    Pak TR, Chung WC, Lund TD, Hinds LR, Clay CM, Handa RJ.
    Endocrinology; 2005 Jan 01; 146(1):147-55. PubMed ID: 15471969
    [Abstract] [Full Text] [Related]

  • 11. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
    Guerini V, Sau D, Scaccianoce E, Rusmini P, Ciana P, Maggi A, Martini PG, Katzenellenbogen BS, Martini L, Motta M, Poletti A.
    Cancer Res; 2005 Jun 15; 65(12):5445-53. PubMed ID: 15958594
    [Abstract] [Full Text] [Related]

  • 12. Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activities by abiraterone.
    Ando T, Nishiyama T, Takizawa I, Ishizaki F, Miyashiro Y, Takeda K, Hara N, Tomita Y.
    Sci Rep; 2016 Aug 26; 6():32198. PubMed ID: 27561382
    [Abstract] [Full Text] [Related]

  • 13. Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells.
    Pak TR, Chung WC, Hinds LR, Handa RJ.
    Endocrinology; 2007 Jul 26; 148(7):3371-82. PubMed ID: 17412808
    [Abstract] [Full Text] [Related]

  • 14. The ERβ ligand 5α-androstane, 3β,17β-diol (3β-diol) regulates hypothalamic oxytocin (Oxt) gene expression.
    Sharma D, Handa RJ, Uht RM.
    Endocrinology; 2012 May 26; 153(5):2353-61. PubMed ID: 22434086
    [Abstract] [Full Text] [Related]

  • 15. Estrogen receptor beta selective ligand 5alpha-Androstane-3beta, 17beta-diol stimulates spermatogonial deoxyribonucleic acid synthesis in rat seminiferous epithelium in vitro.
    Wahlgren A, Svechnikov K, Strand ML, Jahnukainen K, Parvinen M, Gustafsson JA, Söder O.
    Endocrinology; 2008 Jun 26; 149(6):2917-22. PubMed ID: 18292193
    [Abstract] [Full Text] [Related]

  • 16. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q, Titus MA, Fung KM, Lin HK.
    J Cell Biochem; 2008 Aug 01; 104(5):1612-24. PubMed ID: 18320593
    [Abstract] [Full Text] [Related]

  • 17. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
    Pérez-Palacios G, Santillán R, García-Becerra R, Borja-Cacho E, Larrea F, Damián-Matsumura P, González L, Lemus AE.
    J Endocrinol; 2006 Sep 01; 190(3):805-18. PubMed ID: 17003281
    [Abstract] [Full Text] [Related]

  • 18. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation.
    Nunlist EH, Dozmorov I, Tang Y, Cowan R, Centola M, Lin HK.
    J Steroid Biochem Mol Biol; 2004 Jul 01; 91(3):157-70. PubMed ID: 15276623
    [Abstract] [Full Text] [Related]

  • 19. Binding and metabolism of 5alpha-androstane-3alpha, 17 beta-diol and of 5alpha-androstane-3beta, 17 beta-diol in the prostate, seminal vesicles and plasma of male rats: studies in vivo and in vitro.
    Krieg M, Horst HJ, Sterba ML.
    J Endocrinol; 1975 Mar 01; 64(3):529-38. PubMed ID: 1133541
    [Abstract] [Full Text] [Related]

  • 20. Effects of CYP7B1-mediated catalysis on estrogen receptor activation.
    Pettersson H, Lundqvist J, Norlin M.
    Biochim Biophys Acta; 2010 Sep 01; 1801(9):1090-7. PubMed ID: 20553962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.